beyond spring stock news

Beyondspring Incs score of 77 means it scores higher than 77 of stocks in the industry. BeyondSpring now will take its case to the US.

Song Of My Heart Stampers E News Songs Blog Header Stampers

So far 183404 shares have traded compared to average volume of 391817 shares.

. BYSI stock news and headlines to help you in your trading and investing decisions. Stock was up 45 premarket ahead of trading halt Dec. The phase-3 trial was a randomized single blind to patients.

It had slid 27 in the six months through Tuesday. The lowest target price of 37 is a premium of 392 over current prices. PE Ratio TTM The Price to Earnings PE ratio a key valuation measure is.

BeyondSpring stock halted for news pending. A small biopharma stock soars 198 after the company says it will seek FDA approval following a successful cancer-drug trial. This suggests a possible upside of 13925 from the stocks current price.

BeyondSpring Pharmaceuticals Inc NASDAQ. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. The Motley Fool Founded in 1993 in Alexandria VA by brothers David and Tom Gardner The Motley Fool is a multimedia financial-services company dedicated to building the worlds greatest.

Get the latest BeyondSpring Inc. On average they anticipate BeyondSprings share price to reach 3000 in the next twelve months. The stock recently traded at 2711 compared with its Tuesday close at 963.

BYSI has an Overall Score of 47. Stock Ideas and Recommendations. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

BYSI shared the final intention-to-treat ITT dataset from its DUBLIN-3 Phase 3 trial of plinabulin. Why Are BeyondSprings Shares Plunging Today. Get daily stock ideas top-performing Wall Street analysts.

Food and Drug. Real time BeyondSpring Inc. Volume today is light.

Find out what this means to you and get the rest of the rankings on BYSI. Beyondspring Inc also received an overall rating of 47 putting it above 47 of all stocks. A high-level overview of BeyondSpring Inc.

Ahead of the markets open BeyondSpring stock is. Find the latest BeyondSpring Inc. BYSI stock forecast.

ET by Tomi Kilgore BeyondSpring stock price target raised to. 3 Warren Buffett Stocks Down 15 to 90 to Buy Now 1 Stock Down 52 That Is a Screaming Buy 3 Cathie Wood Stocks to Buy and Hold for 10 Years. This is major news for both the fight against lung cancer and BYSI stock.

The word News The word Reviews. The analyst firm set a price target for. Biotechnology is ranked 113 out of the 148 industries.

View the latest news buysell ratings SEC filings and insider transactions for your stocks. Their forecasts range from 500 to 6500. BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with the University of Washington in de novo drug discovery using a.

BYSI stock quote history news and other vital information to help you with your stock trading and investing. Its street high target price of 100 implies an upside of 276 over the next 12 months. No significant news for in the past two years.

BeyondSpring NASDAQBYSI Get Rating and AbbVie NYSEABBV Get Rating are both medical companies but which is the superior stockWe will contrast the two companies based on the strength. View analysts price targets for BeyondSpring or view top-rated stocks among Wall Street analysts. Beyondspring Inc BYSI stock is trading at 220 as of 1115 AM on Monday Mar 21 a decline of -011 or -476 from the previous closing price of 231.

Real-time trade and investing ideas on Beyondspring Inc BYSI from the largest community of traders and investors. Its median target price of 39 is a premium of 467. All six analysts polled by CNN Business rate BYSI stock as a buy or some equivalent.

The latest price target for BeyondSpring NASDAQ. Stock Market Crash. Shares of BeyondSpring Inc NASDAQBYSI are on the move in pre-market trading for April 4.

BYSI a global pharmaceutical company focused on the development of cancer therapeutics today announced that management will participate in a. 24 2021 GLOBE NEWSWIRE -- BeyondSpring the Company or BeyondSpring NASDAQ. The stock has traded between 212 and 227 so far today.

BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference. BYSI was reported by Jefferies on December 2 2021. According to 12 analysts the average rating for BYSI stock is Buy The 12-month stock price forecast is 255 which is.

1 2021 at 758 am. BYSI stock price quote stock graph news analysis.

Beyondspring Nasdaq Bysi Quotes And News Summary Benzinga